Vol. III · No. 172 · Weekend Recap · Saturday, August 22, 2026

Golden Terminal

The Week In Three Numbers No Pre-Market Framing. Markets Reopen Monday, 9:30 ET

Mon & Tue Close, The Bond Rout Three Down Days,
Defense Bid S&P (SPY) $767.45 Tuesday (-0.68%), a third straight loss as the 30-year Treasury touched a 19-year high near 5.33%. Money left the chips (Technology worst, -2.47%) for Energy, Health Care and Staples, and the risk light stayed red a third day

Wednesday's Close, The Vaccine Bounce One Green Day
On A Cancer Shot S&P (SPY) $769.06 (+0.21%), the first up day after three down. Merck jumped 12.6% on a Phase 3 mRNA cancer-vaccine readout and dragged pharma with it, and the market-risk light finally lifted off red to neutral

Thursday's Close, The Bounce Failed Erased In
One Session S&P (SPY) $762.60 (-0.84%). The risk light fell right back to red, Deere beat and raised to rise 6.9% while Walmart beat and cut to fall 9.2%, and the board closed 1 green and 7 red. Last closing tape this run

Dear reader, the author of this week was not a company. It was the 30-year Treasury yield, which touched a 19-year high near 5.33% on Tuesday and never once let the stock market forget it was there. Stocks fell three days running into that number, then got one furious session of relief from the unlikeliest place, a cancer-vaccine trial, before handing the relief back and settling lower. Two roster giants reported Thursday morning and split the difference perfectly: Deere beat and raised its guidance and jumped almost 7%, Walmart beat and cut its guidance and fell more than 9%, its worst day in over four years. Those two prints side by side are the whole market in one afternoon. This tape pays full price for a raise and sells a cut on sight, and right now it is not paying full price for much.

The week opened the way the last one closed, heading down. Tuesday marked a third straight loss, the S&P easing to $767.45 as the long bond hit its 19-year high, and underneath the index the money was already filing toward the exits it prefers in a scare. Energy was the top sector and Health Care and Consumer Staples flipped their momentum lights green on a down day, a defensive divergence, while the chips took the beating: Technology finished dead last, off nearly two and a half percent, with AMD down 4.3%, Broadcom 3.2% and Texas Instruments 3.8%. Caterpillar, the prior session's board-topper, was the single worst mover at down 4.6%. A market that sells its cyclical engine and buys its bond-substitutes is a market playing defense, and it spent the front half of the week doing exactly that.

Wednesday broke the streak, and it broke it on biology, not on the Fed. Merck rose 12.6%, the biggest single move of the week, after it and Moderna reported that a Phase 3 trial of their mRNA cancer vaccine paired with Keytruda hit its primary endpoint. The readout lit up the entire pharma complex, Danaher up 6%, Eli Lilly 4.5%, Thermo Fisher 4.2%, Pfizer 3.6%, and Health Care carried the tape to its first up day in three, the S&P closing at $769.06. The market-risk light this letter reads off the S&P finally lifted off red to neutral. It was the one piece of good news the week generated on its own, and it had nothing to do with inflation, the Fed or the bond market. It was a drug trial.

It did not survive a day. Thursday the S&P fell 0.84% to $762.60, the risk light dropped right back to red, and the single green session was erased in the very next one. The retail read did the damage. Deere reported before the bell, beat by a wide margin and raised its full-year forecast, and rose almost 7%. Walmart reported the same morning, beat on its headline earnings and revenue, but its U.S. same-store sales came in soft and it cut its outlook for the quarter and the year, and the stock fell 9.2%, its worst day in more than four years. Wednesday's pharma heroes handed the vaccine pop straight back, Health Care finished the worst sector on the board, and the momentum count collapsed from three green lights to one against seven red. Energy and Real Estate were the only two sectors that rose, which is another way of saying the only two you buy when you are hiding from everything else.

Friday's own session, the market's answer to the week and to the morning's existing-home-sales number, is not in this recap. By house rule this letter recaps only tape it has already published, so Friday's close gets its verdict in Monday's issue, not this one. What is already on the board tells a whole week's worth of story: a bond rout that pinned the 30-year near a 19-year high, three down days into it, a one-day cancer-vaccine reprieve, and a Thursday that took the reprieve back. Next week the reads turn personal. Intuit reports after Tuesday's bell, then Nvidia and Salesforce after Wednesday's, with Nvidia the marquee number of the month, and the whole calendar builds toward Jackson Hole, where the new Fed chair takes the microphone for the first time the following Friday.

Monday, August 17 through Thursday, August 20, the last closing tape available this run.

Merck jumped 12.6% on a cancer-vaccine blockbuster and bought the whole market one good day. Merck rose 12.6% Wednesday, the biggest move of the week, after it and Moderna said a Phase 3 trial of their mRNA cancer vaccine paired with Keytruda hit its primary endpoint. It did not just lift Merck; it dragged the entire pharma complex with it, Danaher (+6.0%), Eli Lilly (+4.5%), Thermo Fisher (+4.2%) and Pfizer (+3.6%), and single-handedly gave the week its only up day.

Walmart beat and cut, and fell 9.2% for it, its worst day in four years. Walmart reported Thursday before the open, beating on headline earnings ($0.81 against a $0.74 estimate) and revenue, but its U.S. same-store sales missed and it cut its outlook for the third quarter and the full year. The stock fell 9.2%, its worst session in more than four years. In this market a beat wrapped around a guidance cut is a sell, and Walmart was the week's live demonstration of it.

Deere beat and raised, and rose 6.9%, the exact mirror image of Walmart. Deere reported the same Thursday morning as Walmart, beat by a wide margin ($5.10 against a $4.71 estimate) and raised its full-year forecast, and the stock jumped almost 7% to top the roster. Two giants, the same morning, opposite outcomes, and the only difference that mattered was one raised its guide and the other cut it. The pair is the cleanest statement of the year of what this tape rewards.

The chips were the week's consistent loser, down through the chop. Through the down-and-up-and-down week the semiconductors never led and mostly bled: AMD fell 4.3% Tuesday and 3.7% Wednesday, Broadcom dropped 3.2% then 4.6%, Texas Instruments 3.8%, and Nvidia leaked lower into its August 26 report. Technology was the worst sector on Tuesday at down 2.5% and topped the board on no day of the week. The AI trade simply sat this one out.

Energy led while everything else wobbled, and reshuffled the year's leaderboard. Crude turned back up, the oil-fund proxy rising nearly 3% Thursday, and Energy was the best or top sector on multiple days, green on Tuesday and the board-topper on Thursday. The rally pushed EOG Resources and ConocoPhillips into the top four names on the year, at plus 45% and plus 44%, the one corner of the leaderboard the week actually changed.

Unchanged from Issue 171 (Friday, August 21), which ranked Thursday, August 20's session. No new closing session exists to recompute this table since Thursday's close. It will next update with Monday's daily issue.

The held-over board is Thursday's tape, and it is the whole week's mood in a single frame: one green light, seven red, and the two survivors, Energy and Real Estate, are exactly the corners a market buys when it wants out of everything else. Rank the sectors by Thursday's move and the message is the one the week kept sending, the only things bid were the oil hedge and the rate-sensitive corner where the selling had slowed, while the cyclical engine, the banks, the machinery, the retailers and even Wednesday's vaccine-led health-care hero all finished lower. The Dominator board says it loudest: Deere at the top up almost 7% for beating and raising, Walmart at the bottom down more than 9% for beating and cutting. The year's leaderboard barely blinked, AMD still alone at plus 114%, the two energy names the week's only fresh entrants to the top four. One trial lifts a stock for a day. It takes a trend to lift a year, and the trend this week belonged to the bond market.

The Daily Update tracks the tape session by session. Supercycle Trader steps back to the multi-year clock underneath it: the debasement supercycle in gold, energy and hard assets that a 30-year Treasury pinned near a 19-year high, energy leading the board while everything cyclical sells, and gold and silver quietly staying bid only bring into sharper focus. If a week the bond market wrote, with the long bond at a generational high and the oil names climbing the year's leaderboard, has you thinking past the next session, that is the letter built for the longer view.

Strip the week down and it is a contest between one number and one event. The number is the 30-year Treasury yield, which touched a 19-year high near 5.33% on Tuesday and sat over the market like weather for five days, pushing stocks down three sessions in a row. The event was a Merck and Moderna cancer-vaccine trial that hit its mark, and for one Wednesday it was enough, the biggest single move of the week, a pharma-led melt-up and the risk light lifting off red. Then Thursday came and the number won. The risk light fell right back to red, the vaccine pop drained away, and the day's two big earnings reports drew the whole tape in miniature: Deere beat and raised and was rewarded, Walmart beat and cut and was punished with its worst day in four years. On liquidity analyst Michael Howell's framework, a market that cannot hold a rally with the long bond at a generational high is a market whose plumbing is still tight, no matter how good a single day's news. That is his lens, not our forecast, and worth naming as such. But it frames the weekend's real question plainly. A blockbuster can rent the market a day. Only the bond market can give it back the week, and this week it did not. Monday the board resets, and the register keeps opening: Intuit Tuesday, then Nvidia and Salesforce Wednesday.

Brad Hoppmann

Filed from Taintsville, Florida, Pop. < 1,000. 'Taint in the Beltway, 'Taint for Sale. Have a good weekend. The board resets Monday, 9:30 ET.

If this week's recap sharpened your Saturday, the highest compliment you can pay this letter is to forward it to the one person in your circle who would also have wanted to read it.

Disclaimer. The Daily Update is an independent financial publication produced for informational and educational purposes only. Nothing in this issue constitutes personalized investment advice, a recommendation to buy or sell any security, or a solicitation of any kind. The editor and affiliated parties may or may not hold positions in securities mentioned; no such positions are currently disclosed and none are known as of publication. Momentum verdicts (CCI-based GREEN/YELLOW/RED readings) are technical indicators derived from historical price data and carry no predictive guarantee. Past performance is not indicative of future results. This Weekend Recap reuses closing tape and sector-momentum reads already published across Issues 167 through 171 (filed Monday, August 17 through Friday, August 21, 2026, covering the Monday, August 17 through Thursday, August 20 sessions); no new market data was pulled for this issue, and Friday, August 21's own session is not reflected. Synthetic, projected, or estimated data is labeled with the [SYN] highlight or with phrasing such as "est." Consult a licensed financial advisor before making any investment decision.

© 2026 Golden Terminal. All rights reserved. You are receiving this because you subscribed at our website.